Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,538,439
-
Shares change
-
+972,142
-
Total reported value, excl. options
-
$5,473,200
-
Value change
-
+$3,457,200
-
Number of buys
-
9
-
Price
-
$3.56
Significant Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2021
11 filings reported holding IMMX - Immix Biopharma, Inc. - Common Stock as of Q4 2021.
Immix Biopharma, Inc. - Common Stock (IMMX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,538,439 shares
.
Largest 10 shareholders include Murchinson Ltd. (695,600 shares), Lynwood Capital Management Inc. (565,297 shares), Altium Capital Management LP (122,388 shares), UBS Group AG (32,649 shares), Eidelman Virant Capital (29,856 shares), CITADEL ADVISORS LLC (26,474 shares), MILLENNIUM MANAGEMENT LLC (20,470 shares), PVG ASSET MANAGEMENT CORP (20,000 shares), TWO SIGMA SECURITIES, LLC (13,173 shares), and Context Capital Management, LLC (11,532 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.